Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 18:S0039-6257(25)00102-X.
doi: 10.1016/j.survophthal.2025.06.007. Online ahead of print.

Retinopathy of prematurity training and education: A systematic review

Affiliations
Review

Retinopathy of prematurity training and education: A systematic review

Amy Song et al. Surv Ophthalmol. .

Abstract

Globally, management of retinopathy of prematurity (ROP) is limited by a shortage of ophthalmologists who are adequately trained in identifying disease due to limited exposure in ophthalmology residencies and fellowships. We review the current state of ROP education and training and propose strategies to addressing the ROP workforce shortage. Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review was performed using PubMed, Embase, and SCOPUS. Terms that were used in the database searches include telemedicine, tele-education, tele-health, retinopathy of prematurity, artificial intelligence, medical education, training. Advancements in tele-education and artificial intelligence have paved the way for increased accessibility to ROP training, particularly in low- and middle-income countries; however, to ensure that these new modalities are effective in clinical practice and training, ophthalmology residency and fellowship programs must implement relevant education and training into their curricula.

Keywords: Medical education; Ophthalmology fellowship; Ophthalmology residency; Ophthalmology training; Retinopathy of prematurity; Tele-education.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: RVPC: Consultant for Alcon (Fort Worth, TX), AbbVie (North Chicago, IL), Genentech (San Francisco, CA), Adverum (Redwood City, CA), cofounder of Siloam Vision. JPC: Consultant for Genentech (San Francisco, CA), equity owner (Siloam Vision). KEJ: cofounder of Siloam Vision. ASC: consultant (Siloam Vision). RVPC: Unrestricted departmental funding from Research to Prevent Blindness, National Institute of Health (R01 HD107494, R01 EY019474, R01 EY036203, P30 EY010572). JPC: Research to Prevent Blindness (G), Malcolm Marquis Innovation Fund. KEJ: Chief Development Officer (Siloam Vision)

LinkOut - more resources